Colorectal carcinoma and folate

Annali Italiani di Chirurgia

Volumn 84, Issue 2, 2013, Pages 123-131

  Gagliardi, Giuseppina ^a   Biricotti, Marco ^a   Failli, Alessandra ^b   Orsini, Giulia ^b   Consolini, Rita ^b   Migheli, Francesca ^c   Nicolini, Andrea ^c   Spinelli, Claudio ^a   Spisni, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Laboratory of Immunology   (Italy)

^c Department of Human and Environmental Sciences ^*  (Italy)

Author keywords

Colorectal cancer; Epigenetic; Folate

Indexed keywords

FOLIC ACID;

COLORECTAL TUMOR; CPG ISLAND; DNA METHYLATION; HUMAN; MICROSATELLITE INSTABILITY;

COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FOLIC ACID; HUMANS; MICROSATELLITE INSTABILITY;

EID: 84887425031     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Cunningham D, Atkin W, Lenz HJ,et al.: Colorectal cancer. The Lancet, 2010; 375:1030-47.
2. Labianca R, Beretta GD, Kildani B, et al: Colon cancer. Critical Reviews in Oncology/Hematology, 2010; 74:106-33.
3. Ja.sperson KW, Tuohy TM, Neklason DW, Burt RW: Hereditary and familial colon cancer. Gastroenterology, 2010; 138:2044-58.
4. Migliore L, Migheli F, Spisni R, Coppedè F: Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol, 2011; 2011:792362.
5. Shane B: Folate chemistry and metabolism. In. Bailey LB(ed): Folate in Health and Disease. New York: Marcel Dekker, New York, 1995:1-22.
6. Hubner RA, Houlston RS: MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer, 2007; 120:1027-35.
7. Sweeney MR, McPartlin J, Scott J: Folic acid fortification and public health: Report on threshold doses above, which unmetabolised folic acid appear in serum. BMC Public Health, 2007; 7:41-47.
8. Choi SW, Mason JB: Folate status: Effects on pathways of colorectal carcinogenesis. J Nutr, 2002; 132:2413S-18S.
9. Kim,YI: Folic acid supplementation and cancer risk: Point. Cancer Epidemiol. Biomarkers Prev, 2008; 17:2220-225.
10. Kim,YI: Folate and colorectal cancer: An evidence-based critical review. Mol Nutr Food Res, 2007; 51:267-92.
11. Lindzon GM, Medline A, Sohn KJ, Depeint F, Croxford R, Kim Y: Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 2009; 30:1536-543.
12. Sie KK, Medline A, van Weel J, Sohn KJ, Choi SW, Croxford R, Kim YI: Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in in the offspring. Gut, 2011; 60:1687-694.
13. Duthie SJ, Pirie LP, Grant G, Watson AJ, Margison GP: Long term folate deficiency differentially alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no impact on genome-wide DNA methylation. Cancer Prev Res, 2010; 3:92- 100.
14. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH: A temporal association between folic acid fortification and an increase in colorectal cancer rates may he illuminating important biological principles: A hypothesis. Cancer Epidemiol Biomark Prev, 2007; 16:1325-329.
15. Hirsch S. Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L, Bunout D: Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol, 2009; 21:463-69.
16. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S: Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer Gut, 2010; 59:794- 99.
17. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature, 1997; 386:623-27.
18. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JPJ: CpG island methylator phenotype in cobrectal cancer. Natl Acad Sci U S Am, 1998; 96:8684-886.
19. de la Chapelle A, Hampel H: Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol, 2010; 28(20):3380-387.
20. Grady WM, Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology, 2008; 135:1079-99
21. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in tus and risk of colorectal Polyps in African Americans. Digestive colorectal cancers. Nature, 1997; 386:623-27. Disease & Sciences, 2007;52:1462-470.
22. Fensterer H, Radlwimmer B, Strater J, Buchholz M, Aust DE, Julie C, Radvanyi F, Nordlinger B, Belluco C, Van Cutsem E, Kohne CH, Kestler HA, Schwaenen C, Nessling M, Lutz MP, Lichter P, Gress TM; EORTC Gastrointestinal (GI) Group: Matrixcomparative genomic hybridization from multicenter formalinfixed paraffin-embedded colorectal cancer tissue blocks. BMC Cancer, 2007; 7:58.
23. Markowitz SD a, Bertagnolli MM: Molecular origins of cancer: Molecular basis of colorectal cancer. N Eng J Med, 2009; 361:2449- 60.
24. Feinberg AP: Epigenetics at the epicenter of modern medicine. JAMA, 2008; 299(11): 1345-350.
25. Gonzalo V, Lozano JJ, Munoz J, Balaguer F, Pellisé M, Rodriguez de Miguel C, Andreu M, Jover R, Llor X, Giraldez MD, Ocana T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, Castellvi-Bel S, Castells A; Gastrointestinal oncology group of the spanish gastroenterological association: Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS ONE, 2010; 5(1):e8777.
26. Mulero-Navarro S, Esteller M: Chromatin remodeling factor GHD5 is silenced by promoter CpG island hypermethylation in human cancer. Epigenetics, 2008; 3(4):210-15.
27. Wasson GR, McGlynn AP, McNulty H, O'Reilly SL, McKelvey-Martin VJ, McKerr G, Strain JJ, Scott J, Downes CS: Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by filate supplementation. J Nutr, 2006; 136(11):2748-753.
28. Wettergren Y, Odin E, Nilsson S, Carlsson G, and Gustavsson B: p161NK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer. Molecular Medicine, 2008; 14: 412-21.
29. Bernet A, Mazelin L, Coissieux MM et al.: Inactivation of the UNC5C netrin-l receptor is associated with tumor progression in colorectal malignancies. Gastroenterology, 2007; 133:1840-848.
30. Shin SK, Nagasaka T, Jung BH, et al.: Epigenetic and genetic alterations in Netrin-l receptors UNC5C and DCC in human colon cancer Gastroenterology, 2007; 133:1849-857.
31. Hibi K, Nakao A: Highly-methylated colorectal cancers show poorly- differentiated phenotype. Anticancer Research, 2006; 26:4263-266.
32. Kim MS, Lee J, Sidransky D: DNA methylation markers in colorectal cancer. Cancer and Metastasis Reviews, 2010; 29:181-206.
33. Xu XL, Yu J, Zhang HY, et al.: Methylation profile of the promoter CpG islands of 3! genes that may contribute to colorectal carcinogenesis. World Journal of Gastroenterology, 2004; 23:3441-54.
34. Giovannucci, Ascherio, Rimm, Coldtiz, Stampfer, Willet: Physical activity, obesity, and risk for colon cancer and adenoma in men.
35. Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C: Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps: A case-control study- European Journal of Nutrition, 2002; 41,(1):35-43.
36. Ashktorab H, Begum R, Akhgar A, Smoot DT, Elbedawi M, Daremipouran M, Zhao A. Momen B, Giardiello FM: Folate status and risk of colorectal Polyps in African Americans. Digestive Disease &Sciences, 2007;52;1462-470
37. Paun BC, Kukuruga D, Jinetal Z: Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. Cancer, 2010; 116(19):4495-501.
38. Poschl G, Seitz HK: Alcohol and cancer. Alcohol and Alcoholism, 2004; 39(3): 155-65.
39. Seitz HK, Matsuzaki S, Yokoyama A, Homann N, Vakevai S, Wang XD: Alcohol and Cancer. Alcoholism Clinical and Experimental Research, 2001; 5:137-43.
40. Lumeng L, Li TK: Vitamin B6 metabolism in chronic alcohol abuse. Journal of Clinical Investigation. 1974; 53:693-704.
41. Labadarios D. Rossouw JE, McConnell JB, Davis M, Williams R: Vitamin B6 deficiency in chronic liver disease-evidence for increased degradation of pyridoxal-Sphosphate. Gut, 1997; 18,23-27.
42. Barak AJ, Beckenhauer HC, Hidiroglou N, Camilo ME, Selhub J, Tuma,DJ: The relationship of ethanol feeding to the methyl folate trap. Alcohol, 10, 495-97.
43. Lieber, CS: Alcohol and the liver: 1994 update. Gastroenterology, 1994; 106, 1085-105.
44. Hamid A, Kiran M, Rana S, Kaur J: Low folate transport across intestinal basolateral surface is associated with down-regulation of reduced folate carrier in invivo model offolate malabsorption. IUBMB Life, 2009; 61(3):236-43.
45. Arasaradnam RP, Commane DM, Bradburn D, Mathers JC: A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics, 2008; 4(3): 193-98.
46. Berlau Jm Glei M, Pool-Zobel BL: Colon cancer risk factors from nutrition. Anal Bioanal Chem, 2004; 378:737-43.
47. Ferguson LR, Harris PJ: The dietary fibre debate: More food for thought. Lancet, 2003; 361:1487-488.
48. Gao Y, Cao Y, Tan A, Liao C, Mo Z, Gao F.- Glutathione Stransferase M1 polymorphism and sporadic colorectal cancer risk: An updating meta-analysis and HuGE review of 36 case-control studies. Ann Epidemiol, 2010; 20(2): 108-21.
49. Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W: XRCCl polymorphisms and risk of colorectal cancer: A meta-analysis. Int J Colorectal Dis. 2010; 25(3):313-21.
50. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M: methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiology Biomarkers and Prevention, 1999; 8:513-18.
51. Levine AJ, Siegmund KD, Ervin CM et al: The methylenetetrahydrofolate reductase 677C T polymorphism and distal colorectal adenoma risk. Cancer Epidemiology Biomarkers and Prevention, 2000; 9:657-63.
52. Keku T, Millikan R, Worley K et al: 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in Afncan Americans and whites. Cancer Epidemiology Biomarkers and Prevention, 2002; 11:1611-621.
53. Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP: Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecologic Oncology, 2005; 96:173-80.
54. Eaton AM, Sandler R, Carethers JM, Millikan RC, Galanko J and Keku TO; 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiology Biomarkers and Prevention, 2005; 14(8):2023-29.
55. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS: Genetic polymorphisms in one-carbon metabolism: Associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet Carcinogenesis, 2007; 28:672-79.
56. lacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, Fritschi L: The MTHFR C677T and δDNMT3B C- 149T polymorphisms confer different risks for right- and left-sided colorectal cancer. International Journal of Cancer, 2009; 125:84-90.
57. Yamaji T, Iwasaki M, Sasazuki S, Sakamoto H, Yoshida T and Tsugane S: Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma. Cancer Epidemiology Biomarkers and Prevention, 2009; 18:267-74.
58. de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruine AP, Goldbohm RA, van den Brandt PA, Weijenberg MP, van Engeland M: Genetic variants of methyl metabolizing enzymes and epigenetic regulators: Associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiology Biomarkers and Prevention, 2009; 18: 3086-96.
59. Karpinski P, Myszka A, Ramsey D, Misiak B, Gil J, Laczmanska L Grzebieniak Z, Sebzda T, Smigiel R, Stembalska A, Sasiadek MM: Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiology, 2010; 34: 338-44.